z-logo
open-access-imgOpen Access
SUN-164 Use of Metformin, Premixed Insulin, and Glucagon-Like Peptide-1 Receptor Agonist as a Therapeutic Approach for Uncontrolled Type 2 Diabetes Mellitus
Author(s) -
Sasan Fazeli,
Sanjana Rao,
Richard Amdur,
Nicole Ehrhardt
Publication year - 2019
Publication title -
journal of the endocrine society
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.046
H-Index - 20
ISSN - 2472-1972
DOI - 10.1210/js.2019-sun-164
Subject(s) - medicine , metformin , insulin , glycemic , diabetes mellitus , type 2 diabetes , type 2 diabetes mellitus , retrospective cohort study , endocrinology , adverse effect

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom